Top Sell
| Security | Buy | Sell | Buy (1M) | Sell (1M) | Price | Target price | Potential |
|---|---|---|---|---|---|---|---|
| Novan Inc | 0 | 24 | 0 | 3 | €0.001 | - | - |
| Moleculin Biotech Inc | 3 | 27 | 1 | 2 | €0.41 | €18.42 | 4393.659% |
| Evoke Pharma Inc. | 0 | 22 | 0 | 1 | €0.40 | - | - |
| AEterna Zentaris Inc. | 3 | 20 | 1 | 3 | €1.85 | €14.02 | 657.865% |
| Bellicum Pharmaceuticals Inc. | 0 | 14 | 0 | 1 | €0.064 | - | - |
| Neptune Wellness Solutions Inc | 0 | 14 | 0 | 1 | €0.14 | - | - |
| Tonix Pharmaceuticals Holding Corp. | 2 | 15 | 0 | 0 | €2.82 | €5.03 | 78.387% |
| Cyclacel Pharmaceuticals Inc. | 1 | 13 | 0 | 0 | €0.22 | €19.12 | 8591.136% |
| Trevena Inc. | 1 | 13 | 1 | 3 | €0.33 | €8.37 | 2474.277% |
| CEL-SCI Corp. | 0 | 6 | 0 | 0 | €1.34 | - | - |
| Organovo Holdings Inc. | 0 | 5 | 0 | 1 | €0.94 | €3.00 | 219.149% |
| Palatin Technologies Inc. | 0 | 4 | 0 | 0 | €1.70 | - | - |
| Minerva Neurosciences Inc. | 1 | 5 | 0 | 1 | €2.38 | €7.00 | 194.118% |
| Nymox Pharmaceutical Corp. | 0 | 3 | 0 | 0 | €0.23 | - | - |
| iBio Inc. | 0 | 3 | 0 | 2 | €0.18 | €0.20 | 9.290% |
| Medigene AG | 0 | 2 | 0 | 1 | €1.52 | €1.00 | -34.211% |
| Larimar Therapeutics Inc. | 2 | 4 | 0 | 0 | €6.15 | €7.00 | 13.821% |
| Fibrogen Inc. | 2 | 4 | 1 | 1 | €0.95 | €0.000 | -100.000% |
| Omeros Corp. | 2 | 4 | 0 | 0 | €2.83 | - | - |
| Biofrontera AG | 0 | 2 | 0 | 0 | €0.34 | €0.000 | -100.000% |
| Anavex Life Sciences Corp | 0 | 2 | 0 | 1 | €3.21 | - | - |
| BioLine RX Ltd ADR | 0 | 2 | 0 | 0 | €0.57 | - | - |
| Bluebird Bio Inc. | 4 | 6 | 0 | 2 | €0.87 | €6.49 | 642.388% |
| Synthetic Biologics Inc. | 0 | 1 | 0 | 1 | €0.39 | - | - |
| Grifols S.A. ADR | 0 | 1 | 0 | 0 | €5.80 | - | - |